Kimiko Nakajima

3.6k total citations
102 papers, 2.0k citations indexed

About

Kimiko Nakajima is a scholar working on Immunology, Dermatology and Oncology. According to data from OpenAlex, Kimiko Nakajima has authored 102 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 24 papers in Dermatology and 23 papers in Oncology. Recurrent topics in Kimiko Nakajima's work include Psoriasis: Treatment and Pathogenesis (20 papers), Dermatology and Skin Diseases (13 papers) and Urticaria and Related Conditions (11 papers). Kimiko Nakajima is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (20 papers), Dermatology and Skin Diseases (13 papers) and Urticaria and Related Conditions (11 papers). Kimiko Nakajima collaborates with scholars based in Japan, United States and Canada. Kimiko Nakajima's co-authors include Shigetoshi Sano, Mikiro Takaishi, Masahito Tarutani, Hideki Nakajima, Reiko Kamijima, Sayo Kataoka, John DiGiovanni, Ken Miyoshi, Maki Yokogawa and Yoshio Terada and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Kimiko Nakajima

92 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimiko Nakajima Japan 23 999 520 398 370 364 102 2.0k
Basil O. Gerber Switzerland 20 1.3k 1.3× 274 0.5× 326 0.8× 959 2.6× 446 1.2× 22 2.5k
Andrew Gibson United States 28 1.3k 1.3× 167 0.3× 578 1.5× 330 0.9× 789 2.2× 86 3.3k
Asifa Haider United States 20 1.6k 1.6× 912 1.8× 219 0.6× 396 1.1× 426 1.2× 26 2.3k
Jason E. Hawkes United States 20 1.4k 1.4× 1.0k 1.9× 196 0.5× 400 1.1× 546 1.5× 55 2.4k
Nicholas Gulati United States 20 786 0.8× 538 1.0× 139 0.3× 374 1.0× 388 1.1× 77 1.7k
Martijn B. A. van Doorn Netherlands 25 687 0.7× 656 1.3× 237 0.6× 98 0.3× 421 1.2× 100 1.9k
Steven Fakharzadeh United States 24 1.0k 1.0× 606 1.2× 591 1.5× 160 0.4× 313 0.9× 41 2.1k
Helena Ahlfors United Kingdom 26 2.1k 2.1× 266 0.5× 121 0.3× 363 1.0× 871 2.4× 36 3.2k
Eiji Sugiyama Japan 28 591 0.6× 75 0.1× 493 1.2× 389 1.1× 830 2.3× 136 2.5k
Suyan Tian China 18 788 0.8× 533 1.0× 100 0.3× 222 0.6× 422 1.2× 67 1.8k

Countries citing papers authored by Kimiko Nakajima

Since Specialization
Citations

This map shows the geographic impact of Kimiko Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimiko Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimiko Nakajima more than expected).

Fields of papers citing papers by Kimiko Nakajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimiko Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimiko Nakajima. The network helps show where Kimiko Nakajima may publish in the future.

Co-authorship network of co-authors of Kimiko Nakajima

This figure shows the co-authorship network connecting the top 25 collaborators of Kimiko Nakajima. A scholar is included among the top collaborators of Kimiko Nakajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimiko Nakajima. Kimiko Nakajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Mayuko, et al.. (2024). Benefits of the Topical JAK Inhibitor Delgocitinib in a Patient With Pediatric Localized Scleroderma. Pediatric Dermatology. 42(3). 666–668. 1 indexed citations
2.
Miki, Yoshimi, Kimiko Nakajima, Takuya Takeichi, et al.. (2023). Lysophospholipase D from Thermocrispum limits psoriatic inflammation by hydrolyzing epidermal lysoplasmalogen produced by group IIF secreted phospholipase A2. Biochimie. 215. 75–87. 4 indexed citations
3.
Hashida, Yumiko, Kimiko Nakajima, Tomonori Higuchi, Kozo Nakai, & Masanori Daibata. (2023). Involvement of cutavirus in a subset of patients with cutaneous T-cell lymphoma with an unfavorable outcome. Journal of Clinical Virology. 165. 105523–105523. 7 indexed citations
4.
Nakajima, Kimiko, Hisato Suzuki, Mayuko Yamamoto, et al.. (2022). A familial case of periodontal Ehlers–Danlos syndrome lacking skin extensibility and joint hypermobility with a missense mutation in C1R. The Journal of Dermatology. 49(7). 714–718. 1 indexed citations
5.
Nakajima, Kimiko, et al.. (2022). A case of psoriasiform drug eruption caused by temozolomide. SHILAP Revista de lepidopterología. 5(5). 179–183.
6.
Nakajima, Hideki, Kimiko Nakajima, Mikiro Takaishi, et al.. (2021). The Skin–Liver Axis Modulates the Psoriasiform Phenotype and Involves Leucine-Rich α-2 Glycoprotein. The Journal of Immunology. 206(7). 1469–1477. 8 indexed citations
7.
Nakajima, Hideki, et al.. (2021). Severe irritant contact dermatitis from olanexidine gluconate and subsequent skin sensitization. Contact Dermatitis. 86(3). 234–236.
8.
Nakajima, Kimiko, Hideki Nakajima, Yoko Hiraki, et al.. (2020). Skin and hair abnormalities of Cantu syndrome: A congenital hypertrichosis due to a genetic alteration mimicking the pharmacological effect of minoxidil. The Journal of Dermatology. 47(3). 306–310. 9 indexed citations
9.
Nakano, Shoko, Yuko Abe, Kimiko Nakajima, et al.. (2020). Establishment of a mouse model for post‐inflammatory hyperpigmentation. Pigment Cell & Melanoma Research. 34(1). 101–110. 9 indexed citations
10.
Nakajima, Hideki, et al.. (2019). Favorable response to apremilast in a patient with refractory psoriasis verrucosa. The Journal of Dermatology. 46(6). 544–547. 5 indexed citations
11.
Fujita, Hideki, Tadashi Terui, Koremasa Hayama, et al.. (2018). Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP. The Journal of Dermatology. 45(11). 1235–1270. 180 indexed citations
12.
Kobayashi, Tohru, Tohru Kobayashi, Tomio Kobayashi, et al.. (2013). Efficacy of Intravenous Immunoglobulin Combined with Prednisolone Following Resistance to Initial Intravenous Immunoglobulin Treatment of Acute Kawasaki Disease. The Journal of Pediatrics. 163(2). 521–526.e1. 57 indexed citations
13.
Nakajima, Kimiko, Sayo Kataoka, Naoko Goto‐Inoue, et al.. (2012). Ceramide deficiency in the epidermis leads to development of psoriasis-like lesions associated with IL-23-dependent proliferation of γδ-17 cells (62.1). The Journal of Immunology. 188(1_Supplement). 62.1–62.1. 1 indexed citations
14.
Miyoshi, Ken, Mikiro Takaishi, Kimiko Nakajima, et al.. (2010). Stat3 as a Therapeutic Target for the Treatment of Psoriasis: A Clinical Feasibility Study with STA-21, a Stat3 Inhibitor. Journal of Investigative Dermatology. 131(1). 108–117. 202 indexed citations
15.
Ujihara, Mayumi, Kimiko Nakajima, Mayuko Yamamoto, et al.. (2009). Epidermal triglyceride levels are correlated with severity of ichthyosis in Dorfman–Chanarin syndrome. Journal of Dermatological Science. 57(2). 102–107. 26 indexed citations
16.
Nakajima, Kimiko, et al.. (2004). D-penicillamine-induced Pemphigus with Inconsistent Anti-desmoglein Antibodies. The Nishinihon Journal of Dermatology. 66(2). 128–131. 2 indexed citations
17.
Hori, Akihiro, et al.. (1997). [Evaluation of ischemic heart disease using the index of relative 99mTc-tetrofosmin uptake increase at exercise].. PubMed. 34(7). 433–41. 2 indexed citations
18.
Sundt, Thoralf M., Christian LeGuern, Sharon Germana, et al.. (1992). Characterization of a polymorphism of CD4 in miniature swine. The Journal of Immunology. 148(10). 3195–3201. 18 indexed citations
19.
Inagaki, Masaru, Tohru Ohe, Mokuo Matsuhisa, et al.. (1984). ELECTROPHYSIOLOGICAL CHARACTERISTICS OF WOLFF-PARKINSON-WHITE SYNDROME WITH PAROXYSMAL ATRIAL FIBRILLATION : Arrhythmias (II), Electrophysiology (II), Mapping : III : 48 Annual Scientific Meeting, Japanese Circulation Society. Japanese Circulation Journal-english Edition. 48(8). 858–859. 1 indexed citations
20.
Abe, Tatsuya, Masaya Yamamoto, Kimiko Nakajima, et al.. (1968). Kongenitale nichtsphärozytäre hämolytische Anämien durch Mangel an Glucose-6-Phosphat-Dehydrogenase der Erythrozyten in einer japanischen Familie. Annals of Hematology. 17(3). 143–151. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Basil O. Gerber Breakdown of academic impact, for papers by Andrew Gibson Breakdown of academic impact, for papers by Asifa Haider Breakdown of academic impact, for papers by Jason E. Hawkes Breakdown of academic impact, for papers by Nicholas Gulati Breakdown of academic impact, for papers by Martijn B. A. van Doorn Breakdown of academic impact, for papers by Steven Fakharzadeh Breakdown of academic impact, for papers by Helena Ahlfors Breakdown of academic impact, for papers by Eiji Sugiyama Breakdown of academic impact, for papers by Suyan Tian
Rankless by CCL
2026